Floatz logo

Flutemetamol

Atherosclerosis

Maastricht University Medical CenterSmall moleculePhase 2/3Dormant
B
56/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
41/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the Atherosclerosis cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
Rajaie Cardiovascular Medical and Research Center
Phase 4BBB
SIMVASTATIN
Northern California Institute of Research and Education
Phase 4BBB
ADVICOR COMPONENT NIACIN
University of Washington
Phase 4BB
Lipitor
Erasmus Medical Center
Phase 4BB
Plavix
Ewha Womans University Seoul Hospital
Phase 4BB

View all 44 →

Same molecule, other indications

Flutemetamol is also rated in:

Alzheimer diseaseDormant
BB
Indicative ·
64 / 100
View asset →
Brain Fibrillarab LevelsDormant
B
Indicative ·
61 / 100
View asset →
normal pressure hydrocephalusDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →